Click Here!
4: Maternal and fetal outcomes in women with pre-eclampsia (mild and severe) according to antenatal hyperuricaemia, severe hypertension or proteinuria (see text for definitions). Data are percentages or means (standard deviation).

Hyper-uricaemiaNormal uric acidPSevere hypertensionMild hypertensionPNo proteinuriaProteinuriaP

n481344171654160665
Age (years)28 (5)28 (5) 0.6827 (5)28 (5)0.3828 (5)28 (5)0.82
Nulliparae (%)65570.0473590.001*68600.09
Gestation at presentation (weeks)36 (5)35 (5)0.3035 (4)35 (5)0.5834 (6)36 (5)0.001*
Gestation at delivery (weeks)38 (2)37 (3) 0.0001*37 (3)38 (2)< 0.0001*36 (4)38 (2)< 0.0001*
Hyperuricaemia (%)----7654< 0.0001*7953< 0.0001*
Maternal complications
Severe hypertension27%12%< 0.0001*----53%13%< 0.0001*
Thrombocytopenia13%6%0.0015*21%7%< 0.0001*19%8%< 0.0001*
Proteinuria26%10%< 0.0001*50% 11%< 0.0001*----
Renal impairment10%2%< 0.0001*16%5%< 0.0001*21%1%< 0.0001*
Liver disease 13%5% 0.0002*27%5%< 0.0001*21%7%< 0.0001*
Neurological17%5%< 0.0001*36%6%< 0.0001* 33%7%< 0.0001*
Laboratory data
Plasma creatinine (mmol/L)0.08 (0.04)0.07 (0.02)< 0.0001*0.07 (0.02)0.07 (0.04)0.580.08 (0.07)0.07 (0.02)0.12
Plasma uric acid (mmol/L)0.44 (0.19)0.30 (0.04)< 0.0001*0.42 (0.08)0.38 (0.18)0.001*0.42 (0.09)0.38 (0.18)< 0.0001*
Plasma albumin (g/L)33 (5)34 (5) 0.0003*32 (6)34 (5)0.0001*30 (7)34 (4) < 0.0001*
Haemoglobin (g/L)119 (22)121 (18) 0.11118 (30)121 (17)0.25115 (32)122 (16) 0.014
Haematocrit (%)35.1 (5.9)35.8 (4.9) 0.0934.7 (6.6)35.6 (5.2)0.1333.9 (6.8)35.8 (5.1) 0.003*
Platelets (x 109/L)218 (83)237 (78)0.0011* 204 (84)232 (80)0.0001*196 (79)234 (81) < 0.0001*
Fetal complications
SGA (%)23130.0008*27170.004*24170.044
PNM (per 1000)1590.452980.02*3860.001*
Birthweight (g)2902 (722)3089 (663) 0.0002*2585 (798)3084 (634)< 0.0001*2498 (866)3097 (601)< 0.0001*

* Statistically significant (see text). SGA = small-for-gestational-age. PNM = perinatal mortality.
Back to article

Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".

<URL: http://www.mja.com.au/> © 1999 Medical Journal of Australia.
We appreciate your comments.